_id

692d6a36b93c8af7a3960534

Ticker

LGNYZ

Name

Ligand Pharmaceuticals Inc General Contingent Value Rt

Exchange

PINK

Address

555 Heritage Drive, Jupiter, FL, United States, 33458

Country

USA

Sector

Industry

Currency

USD

Website

https://www.ligand.com

Description

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI, a dual endothelin and angiotensin II receptor antagonist for immunoglobulin A nephropathy; Ohtuvayre for respiratory disease; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; LYTENAVA to treat Opthamology; MEKINIST for cardiology; MINNEBRO for metabolic disease; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, JZP341, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; CE-furosemide for cardiology; CE-Meloxicam for neurology; V117, CX2101A, and Sitavig for infectious disease; REV-0100, OPT-302, and Reproxalap for opthamology; Vilazodone and Topiramate Injection for CNS; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

Last Close

0.0425

Volume

1642337

Current Price

0.037

Change

5.8823529411764595

Last Updated

2025-12-01T10:13:10.527Z

Image

https://logo.clearbit.com/www.ligand.com

Ipo Date

-

Market Cap

-

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.9971428571428571

Sentiment Sources

7

Current Quarter

2025-06-30

Revenue

115461000

Cost Of Revenue

24271000

Gross Profit

-68688999

Operating Expenses

36259000

Operating Income

54931000

Interest Expense

2020000

Pretax Income

141137000

Net Income

104521000

Eps

5.182002974714923

Dividends Per Share

-

Shares Outstanding

0

Income Tax Expense

103533000

EBITDA

124882000

Operating Margin

47.57537177055456

Total Other Income Expense Net

86206000

Cash

664522000

Short Term Investments

177351000

Receivables

58096000

Inventories

11900000

Total Current Assets

753920000

Property Plant Equipment

11075000

Total Assets

1476772000

Payables

8584000

Short Term Debt

1089000

Long Term Debt

-

Total Liabilities

526601000

Equity

950171000

Depreciation

9361000

Change In Working Capital

-6171000

Cash From Operations

15799000

Capital Expenditures

214000

Cash From Investing

-10667000

Cash From Financing

14997000

Net Change In Cash

19680000

PE

-

PB

0.0007854270441846783

ROE

11.00023048482852

ROA

7.07766669465564

FCF

15585000

Fcf Percent

0.13498064281445682

Piotroski FScore

3

Health Score

72

Deep Value Investing Score

8.5

Defensive Investing Score

6.5

Dividend Investing Score

3

Economic Moat Investing Score

8

Garp Investing Score

6

Growth Investing Score

4.5

Momentum Investing Score

2.5

Net Net Investing Score

3.5

Quality Investing Score

8.5

Value Investing Score

9

Quarters > 0 > quarter

2025-06-30

Quarters > 0 > income Statement > revenue

115461000

Quarters > 0 > income Statement > cost Of Revenue

24271000

Quarters > 0 > income Statement > gross Profit

-68688999

Quarters > 0 > income Statement > operating Expenses

36259000

Quarters > 0 > income Statement > operating Income

54931000

Quarters > 0 > income Statement > interest Expense

2020000

Quarters > 0 > income Statement > pretax Income

141137000

Quarters > 0 > income Statement > net Income

104521000

Quarters > 0 > income Statement > eps

5.182002974714923

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

20170000

Quarters > 0 > income Statement > income Tax Expense

103533000

Quarters > 0 > income Statement > EBITDA

124882000

Quarters > 0 > income Statement > operating Margin

47.57537177055456

Quarters > 0 > income Statement > total Other Income Expense Net

86206000

Quarters > 0 > balance Sheet > cash

664522000

Quarters > 0 > balance Sheet > short Term Investments

177351000

Quarters > 0 > balance Sheet > receivables

58096000

Quarters > 0 > balance Sheet > inventories

11900000

Quarters > 0 > balance Sheet > total Current Assets

753920000

Quarters > 0 > balance Sheet > property Plant Equipment

11075000

Quarters > 0 > balance Sheet > total Assets

1476772000

Quarters > 0 > balance Sheet > payables

8584000

Quarters > 0 > balance Sheet > short Term Debt

1089000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

526601000

Quarters > 0 > balance Sheet > equity

950171000

Quarters > 0 > cash Flow > net Income

4847000

Quarters > 0 > cash Flow > depreciation

9361000

Quarters > 0 > cash Flow > change In Working Capital

-6171000

Quarters > 0 > cash Flow > cash From Operations

15799000

Quarters > 0 > cash Flow > capital Expenditures

214000

Quarters > 0 > cash Flow > cash From Investing

-10667000

Quarters > 0 > cash Flow > cash From Financing

14997000

Quarters > 0 > cash Flow > net Change In Cash

19680000

Quarters > 0 > ratios > PE

5.182002974714923

Quarters > 0 > ratios > PB

0.0007854270441846783

Quarters > 0 > ratios > ROE

11.00023048482852

Quarters > 0 > ratios > ROA

7.07766669465564

Quarters > 0 > ratios > FCF

15585000

Quarters > 0 > ratios > Piotroski FScore

3

Quarters > 0 > ratios > fcf Percent

0.13498064281445682

Quarters > 0 > health Score

72

Quarters > 1 > quarter

2025-03-31

Quarters > 1 > income Statement > revenue

45333000

Quarters > 1 > income Statement > cost Of Revenue

13106000

Quarters > 1 > income Statement > gross Profit

32226999

Quarters > 1 > income Statement > operating Expenses

68886000

Quarters > 1 > income Statement > operating Income

-36216000

Quarters > 1 > income Statement > interest Expense

867000

Quarters > 1 > income Statement > pretax Income

-50180000

Quarters > 1 > income Statement > net Income

-42451000

Quarters > 1 > income Statement > eps

-2.2120264707414936

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

19191000

Quarters > 1 > income Statement > income Tax Expense

-7729000

Quarters > 1 > income Statement > EBITDA

-36216000

Quarters > 1 > income Statement > operating Margin

-79.88882271193171

Quarters > 1 > income Statement > total Other Income Expense Net

-13964000

Quarters > 1 > balance Sheet > cash

47989000

Quarters > 1 > balance Sheet > short Term Investments

160912000

Quarters > 1 > balance Sheet > receivables

42831000

Quarters > 1 > balance Sheet > inventories

14614000

Quarters > 1 > balance Sheet > total Current Assets

309316000

Quarters > 1 > balance Sheet > property Plant Equipment

10492000

Quarters > 1 > balance Sheet > total Assets

905435000

Quarters > 1 > balance Sheet > payables

5366000

Quarters > 1 > balance Sheet > short Term Debt

883000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

109901000

Quarters > 1 > balance Sheet > equity

795534000

Quarters > 1 > cash Flow > net Income

-42451000

Quarters > 1 > cash Flow > depreciation

9341000

Quarters > 1 > cash Flow > change In Working Capital

-5168000

Quarters > 1 > cash Flow > cash From Operations

-25516000

Quarters > 1 > cash Flow > capital Expenditures

214000

Quarters > 1 > cash Flow > cash From Investing

4894000

Quarters > 1 > cash Flow > cash From Financing

-4747000

Quarters > 1 > cash Flow > net Change In Cash

-24318000

Quarters > 1 > ratios > PE

-2.2120264707414936

Quarters > 1 > ratios > PB

0.0008925665025002075

Quarters > 1 > ratios > ROE

-5.336164136290844

Quarters > 1 > ratios > ROA

-4.688464660632734

Quarters > 1 > ratios > FCF

-25730000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-0.5675777027772263

Quarters > 1 > health Score

34

Quarters > 2 > quarter

2024-12-31

Quarters > 2 > income Statement > revenue

42812000

Quarters > 2 > income Statement > cost Of Revenue

11607000

Quarters > 2 > income Statement > gross Profit

31205000

Quarters > 2 > income Statement > operating Expenses

30030000

Quarters > 2 > income Statement > operating Income

-9637000

Quarters > 2 > income Statement > interest Expense

883000

Quarters > 2 > income Statement > pretax Income

-39200000

Quarters > 2 > income Statement > net Income

-31088000

Quarters > 2 > income Statement > eps

-1.699726626571897

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

18290000

Quarters > 2 > income Statement > income Tax Expense

-8112000

Quarters > 2 > income Statement > EBITDA

-29099000

Quarters > 2 > income Statement > operating Margin

-22.51004391292161

Quarters > 2 > income Statement > total Other Income Expense Net

-29563000

Quarters > 2 > balance Sheet > cash

256165000

Quarters > 2 > balance Sheet > short Term Investments

183858000

Quarters > 2 > balance Sheet > receivables

38376000

Quarters > 2 > balance Sheet > inventories

14114000

Quarters > 2 > balance Sheet > total Current Assets

331559000

Quarters > 2 > balance Sheet > property Plant Equipment

24806000

Quarters > 2 > balance Sheet > total Assets

941774000

Quarters > 2 > balance Sheet > payables

5233000

Quarters > 2 > balance Sheet > short Term Debt

1290000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

111335000

Quarters > 2 > balance Sheet > equity

830439000

Quarters > 2 > cash Flow > net Income

-31088000

Quarters > 2 > cash Flow > depreciation

8021000

Quarters > 2 > cash Flow > change In Working Capital

11602000

Quarters > 2 > cash Flow > cash From Operations

28471000

Quarters > 2 > cash Flow > capital Expenditures

712000

Quarters > 2 > cash Flow > cash From Investing

-38623000

Quarters > 2 > cash Flow > cash From Financing

20506000

Quarters > 2 > cash Flow > net Change In Cash

8688000

Quarters > 2 > ratios > PE

-1.699726626571897

Quarters > 2 > ratios > PB

0.0008149063326746454

Quarters > 2 > ratios > ROE

-3.743562140024734

Quarters > 2 > ratios > ROA

-3.301004274910966

Quarters > 2 > ratios > FCF

27759000

Quarters > 2 > ratios > Piotroski FScore

2

Quarters > 2 > ratios > fcf Percent

0.6483929739325422

Quarters > 2 > health Score

53

Quarters > 3 > quarter

2024-09-30

Quarters > 3 > income Statement > revenue

51812000

Quarters > 3 > income Statement > cost Of Revenue

12495000

Quarters > 3 > income Statement > gross Profit

39317000

Quarters > 3 > income Statement > operating Expenses

36174000

Quarters > 3 > income Statement > operating Income

3143000

Quarters > 3 > income Statement > interest Expense

741000

Quarters > 3 > income Statement > pretax Income

-6339000

Quarters > 3 > income Statement > net Income

-7172000

Quarters > 3 > income Statement > eps

-0.3893805309734513

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

18419000

Quarters > 3 > income Statement > income Tax Expense

-12267000

Quarters > 3 > income Statement > EBITDA

3969000

Quarters > 3 > income Statement > operating Margin

6.066162279008724

Quarters > 3 > income Statement > total Other Income Expense Net

-9482000

Quarters > 3 > balance Sheet > cash

63619000

Quarters > 3 > balance Sheet > short Term Investments

156024000

Quarters > 3 > balance Sheet > receivables

34318000

Quarters > 3 > balance Sheet > inventories

16740000

Quarters > 3 > balance Sheet > total Current Assets

309388000

Quarters > 3 > balance Sheet > property Plant Equipment

25191000

Quarters > 3 > balance Sheet > total Assets

954866000

Quarters > 3 > balance Sheet > payables

4694000

Quarters > 3 > balance Sheet > short Term Debt

1090000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

113688000

Quarters > 3 > balance Sheet > equity

841178000

Quarters > 3 > cash Flow > net Income

-7172000

Quarters > 3 > cash Flow > depreciation

7287000

Quarters > 3 > cash Flow > change In Working Capital

-633000

Quarters > 3 > cash Flow > cash From Operations

36628000

Quarters > 3 > cash Flow > capital Expenditures

3578000

Quarters > 3 > cash Flow > cash From Investing

-46507000

Quarters > 3 > cash Flow > cash From Financing

54982000

Quarters > 3 > cash Flow > net Change In Cash

45480000

Quarters > 3 > ratios > PE

-0.3893805309734513

Quarters > 3 > ratios > PB

0.0008101769185594487

Quarters > 3 > ratios > ROE

-0.852613834408413

Quarters > 3 > ratios > ROA

-0.7511001543672097

Quarters > 3 > ratios > FCF

33050000

Quarters > 3 > ratios > Piotroski FScore

2

Quarters > 3 > ratios > fcf Percent

0.637883115880491

Quarters > 3 > health Score

53

Annuals > 0 > quarter

2024-12-31

Annuals > 0 > income Statement > revenue

167133000

Annuals > 0 > income Statement > cost Of Revenue

46333000

Annuals > 0 > income Statement > gross Profit

120800000

Annuals > 0 > income Statement > operating Expenses

97779000

Annuals > 0 > income Statement > operating Income

23021000

Annuals > 0 > income Statement > interest Expense

3037000

Annuals > 0 > income Statement > pretax Income

2518000

Annuals > 0 > income Statement > net Income

9068000

Annuals > 0 > income Statement > eps

0.49579004920721703

Annuals > 0 > income Statement > dividends Per Share

-

Annuals > 0 > income Statement > shares Outstanding

18290000

Annuals > 0 > income Statement > income Tax Expense

-6550000

Annuals > 0 > income Statement > EBITDA

42940000

Annuals > 0 > income Statement > operating Margin

13.77406017961743

Annuals > 0 > income Statement > total Other Income Expense Net

25124000

Annuals > 0 > balance Sheet > cash

72307000

Annuals > 0 > balance Sheet > short Term Investments

183858000

Annuals > 0 > balance Sheet > receivables

38376000

Annuals > 0 > balance Sheet > inventories

14114000

Annuals > 0 > balance Sheet > total Current Assets

331559000

Annuals > 0 > balance Sheet > property Plant Equipment

24806000

Annuals > 0 > balance Sheet > total Assets

941774000

Annuals > 0 > balance Sheet > payables

5233000

Annuals > 0 > balance Sheet > short Term Debt

1290000

Annuals > 0 > balance Sheet > long Term Debt

-

Annuals > 0 > balance Sheet > total Liabilities

111335000

Annuals > 0 > balance Sheet > equity

830439000

Annuals > 0 > cash Flow > net Income

-4032000

Annuals > 0 > cash Flow > depreciation

33908000

Annuals > 0 > cash Flow > change In Working Capital

19356000

Annuals > 0 > cash Flow > cash From Operations

97047000

Annuals > 0 > cash Flow > capital Expenditures

1821000

Annuals > 0 > cash Flow > cash From Investing

-143664000

Annuals > 0 > cash Flow > cash From Financing

97567000

Annuals > 0 > cash Flow > net Change In Cash

49353000

Annuals > 0 > ratios > PE

0.49579004920721703

Annuals > 0 > ratios > PB

0.0011012247738846563

Annuals > 0 > ratios > ROE

1.0919525696649603

Annuals > 0 > ratios > ROA

0.9628637019072517

Annuals > 0 > ratios > FCF

95226000

Annuals > 0 > ratios > Piotroski FScore

4

Annuals > 0 > ratios > fcf Percent

0.5697618064655096

Annuals > 0 > health Score

70

Annuals > 1 > quarter

2023-12-31

Annuals > 1 > income Statement > revenue

131314000

Annuals > 1 > income Statement > cost Of Revenue

43288000

Annuals > 1 > income Statement > gross Profit

88026000

Annuals > 1 > income Statement > operating Expenses

78205000

Annuals > 1 > income Statement > operating Income

9821000

Annuals > 1 > income Statement > interest Expense

656000

Annuals > 1 > income Statement > pretax Income

63660000

Annuals > 1 > income Statement > net Income

52154000

Annuals > 1 > income Statement > eps

2.937095230050121

Annuals > 1 > income Statement > dividends Per Share

-

Annuals > 1 > income Statement > shares Outstanding

17757000

Annuals > 1 > income Statement > income Tax Expense

9841000

Annuals > 1 > income Statement > EBITDA

101727000

Annuals > 1 > income Statement > operating Margin

7.479019754177011

Annuals > 1 > income Statement > total Other Income Expense Net

53839000

Annuals > 1 > balance Sheet > cash

22954000

Annuals > 1 > balance Sheet > short Term Investments

147355000

Annuals > 1 > balance Sheet > receivables

39312000

Annuals > 1 > balance Sheet > inventories

23969000

Annuals > 1 > balance Sheet > total Current Assets

237429000

Annuals > 1 > balance Sheet > property Plant Equipment

25062000

Annuals > 1 > balance Sheet > total Assets

787216000

Annuals > 1 > balance Sheet > payables

2427000

Annuals > 1 > balance Sheet > short Term Debt

410000

Annuals > 1 > balance Sheet > long Term Debt

-

Annuals > 1 > balance Sheet > total Liabilities

86303000

Annuals > 1 > balance Sheet > equity

700913000

Annuals > 1 > cash Flow > net Income

11696000

Annuals > 1 > cash Flow > depreciation

35203000

Annuals > 1 > cash Flow > change In Working Capital

-34402000

Annuals > 1 > cash Flow > cash From Operations

48628000

Annuals > 1 > cash Flow > capital Expenditures

53849000

Annuals > 1 > cash Flow > cash From Investing

-11682000

Annuals > 1 > cash Flow > cash From Financing

-58998000

Annuals > 1 > cash Flow > net Change In Cash

-22052000

Annuals > 1 > ratios > PE

2.937095230050121

Annuals > 1 > ratios > PB

0.0012667049976245268

Annuals > 1 > ratios > ROE

7.440866412807296

Annuals > 1 > ratios > ROA

6.62511940814211

Annuals > 1 > ratios > FCF

-5221000

Annuals > 1 > ratios > Piotroski FScore

3

Annuals > 1 > ratios > fcf Percent

-0.039759660051479656

Annuals > 1 > health Score

62

Annuals > 2 > quarter

2022-12-31

Annuals > 2 > income Statement > revenue

196245000

Annuals > 2 > income Statement > cost Of Revenue

77100000

Annuals > 2 > income Statement > gross Profit

119145000

Annuals > 2 > income Statement > operating Expenses

106308000

Annuals > 2 > income Statement > operating Income

12837000

Annuals > 2 > income Statement > interest Expense

1799000

Annuals > 2 > income Statement > pretax Income

36011000

Annuals > 2 > income Statement > net Income

-33361000

Annuals > 2 > income Statement > eps

-1.9777685558453877

Annuals > 2 > income Statement > dividends Per Share

-

Annuals > 2 > income Statement > shares Outstanding

16868000

Annuals > 2 > income Statement > income Tax Expense

41230000

Annuals > 2 > income Statement > EBITDA

81204000

Annuals > 2 > income Statement > operating Margin

6.541313154475273

Annuals > 2 > income Statement > total Other Income Expense Net

23174000

Annuals > 2 > balance Sheet > cash

45006000

Annuals > 2 > balance Sheet > short Term Investments

166864000

Annuals > 2 > balance Sheet > receivables

35038000

Annuals > 2 > balance Sheet > inventories

13294000

Annuals > 2 > balance Sheet > total Current Assets

263601000

Annuals > 2 > balance Sheet > property Plant Equipment

27491000

Annuals > 2 > balance Sheet > total Assets

762668000

Annuals > 2 > balance Sheet > payables

5307000

Annuals > 2 > balance Sheet > short Term Debt

-5486000

Annuals > 2 > balance Sheet > long Term Debt

-

Annuals > 2 > balance Sheet > total Liabilities

165183000

Annuals > 2 > balance Sheet > equity

597485000

Annuals > 2 > cash Flow > net Income

-5219000

Annuals > 2 > cash Flow > depreciation

43394000

Annuals > 2 > cash Flow > change In Working Capital

65677000

Annuals > 2 > cash Flow > cash From Operations

137850000

Annuals > 2 > cash Flow > capital Expenditures

17923000

Annuals > 2 > cash Flow > cash From Investing

163624000

Annuals > 2 > cash Flow > cash From Financing

-275990000

Annuals > 2 > cash Flow > net Change In Cash

25484000

Annuals > 2 > ratios > PE

-1.9777685558453877

Annuals > 2 > ratios > PB

0.0014115835543988553

Annuals > 2 > ratios > ROE

-5.5835711356770465

Annuals > 2 > ratios > ROA

-4.374249345717927

Annuals > 2 > ratios > FCF

119927000

Annuals > 2 > ratios > Piotroski FScore

2

Annuals > 2 > ratios > fcf Percent

0.6111085632754975

Annuals > 2 > health Score

53

Annuals > 3 > quarter

2021-12-31

Annuals > 3 > income Statement > revenue

241544000

Annuals > 3 > income Statement > cost Of Revenue

96273000

Annuals > 3 > income Statement > gross Profit

145271000

Annuals > 3 > income Statement > operating Expenses

79020000

Annuals > 3 > income Statement > operating Income

66251000

Annuals > 3 > income Statement > interest Expense

19619000

Annuals > 3 > income Statement > pretax Income

72205000

Annuals > 3 > income Statement > net Income

57138000

Annuals > 3 > income Statement > eps

3.31311608488925

Annuals > 3 > income Statement > dividends Per Share

-

Annuals > 3 > income Statement > shares Outstanding

17246000

Annuals > 3 > income Statement > income Tax Expense

-4148000

Annuals > 3 > income Statement > EBITDA

133161000

Annuals > 3 > income Statement > operating Margin

27.428129036531644

Annuals > 3 > income Statement > total Other Income Expense Net

5954000

Annuals > 3 > balance Sheet > cash

19522000

Annuals > 3 > balance Sheet > short Term Investments

321586000

Annuals > 3 > balance Sheet > receivables

91646000

Annuals > 3 > balance Sheet > inventories

27326000

Annuals > 3 > balance Sheet > total Current Assets

464751000

Annuals > 3 > balance Sheet > property Plant Equipment

53260000

Annuals > 3 > balance Sheet > total Assets

1297590000

Annuals > 3 > balance Sheet > payables

8403000

Annuals > 3 > balance Sheet > short Term Debt

2099000

Annuals > 3 > balance Sheet > long Term Debt

-

Annuals > 3 > balance Sheet > total Liabilities

476431000

Annuals > 3 > balance Sheet > equity

821159000

Annuals > 3 > cash Flow > net Income

76353000

Annuals > 3 > cash Flow > depreciation

41337000

Annuals > 3 > cash Flow > change In Working Capital

-57004000

Annuals > 3 > cash Flow > cash From Operations

78798000

Annuals > 3 > cash Flow > capital Expenditures

8761000

Annuals > 3 > cash Flow > cash From Investing

30523000

Annuals > 3 > cash Flow > cash From Financing

-137761000

Annuals > 3 > cash Flow > net Change In Cash

-28440000

Annuals > 3 > ratios > PE

3.31311608488925

Annuals > 3 > ratios > PB

0.001050101137538528

Annuals > 3 > ratios > ROE

6.9582139390787905

Annuals > 3 > ratios > ROA

4.4033939842323075

Annuals > 3 > ratios > FCF

70037000

Annuals > 3 > ratios > Piotroski FScore

4

Annuals > 3 > ratios > fcf Percent

0.2899554532507535

Annuals > 3 > health Score

74

Valuation > metrics > PE

5.182002974714923

Valuation > metrics > PB

0.0007854270441846783

Valuation > final Score

90

Valuation > verdict

74.1% Undervalued

Profitability > metrics > ROE

11.00023048482852

Profitability > metrics > ROA

13.863672538200339

Profitability > metrics > Net Margin

0.9052493915694477

Profitability > final Score

82

Profitability > verdict

Adequate

Risk > metrics > Debt Equity

0.5542170830303177

Risk > metrics > Interest Coverage

27.193564356435644

Risk > final Score

88

Risk > verdict

Low

Liquidity > metrics > Current Ratio

77.94065956786933

Liquidity > metrics > Quick Ratio

76.71043109686757

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

70

Prev Valuations > 2

70

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

-107

Prev Risks > 1

16

Prev Risks > 2

77

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2026-01-20T23:12:23.096Z